Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference39 articles.
1. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines;AlonsoDeVelasco;Microbiol Rev,1995
2. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I;Hausdorff;Clin Infect Dis,2000
3. Six newly recognized types of Streptococcus pneumoniae;Henrichsen;J Clin Microbiol,1995
4. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente;Black;Pediatr Infect Dis J,2004
5. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine;Black;Pediatr Infect Dis J,2001
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development;Vaccines;2024-08-28
2. Serotype 3 Antibody Response and Antibody Functionality Compared to Serotype 19A Following 13-valent Pneumococcal Conjugate Immunization in Children;Pediatric Infectious Disease Journal;2023-11-30
3. Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C;Vaccine;2023-11
4. Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children;Vaccine;2023-05
5. Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors;Vaccine;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3